tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB

Seres Therapeutics (MCRB) Similar Stocks

Compare
1,049 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Seres Therapeutics
$0.81
$138.57M
-22.76%
2 Buy
0 Hold
0 Sell
Moderate Buy
Amicus
$9.07
$2.94B
-33.11%
7 Buy
3 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$94.35
$5.91B
8.13%
11 Buy
4 Hold
0 Sell
Moderate Buy
Editas Medicine
$2.06
$170.05M
-74.02%
4 Buy
9 Hold
2 Sell
Hold
Intellia Therapeutics
$12.25
$1.17B
-54.93%
11 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$50.43
$4.48B
-41.49%
12 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MCRB
Seres Therapeutics
0.81
-0.29
-26.36%
FOLD
Amicus
9.07
-4.33
-32.31%
BPMC
Blueprint Medicines
94.35
8.35
9.71%
EDIT
Editas Medicine
2.06
-5.87
-74.02%
NTLA
Intellia Therapeutics
12.25
-14.93
-54.93%
CRSP
Crispr Therapeutics AG
50.43
-35.76
-41.49%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis